Clinical Trials Directory

Trials / Completed

CompletedNCT04290507

Epidemiology and Outcome of Anaphylactic Shocks Admitted to Intensive Care Unit

Epidemiology and Outcome of Anaphylactic Shocks Admitted to Intensive Care Unit: a French Retrospective Multicenter Study

Status
Completed
Phase
Study type
Observational
Enrollment
339 (actual)
Sponsor
Central Hospital, Nancy, France · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Anaphylaxis is a severe life-threatening reaction following exposure to an antigen. Its incidence is progressively increasing in the general population over years, accompanied with an increased number of hospitalizations. Although rare, this condition is often associated with a significant morbidity and mortality. The mortality rate has been recently estimated at 0.84 (95% CI, 0.79 to 0.88) per million per year in the French adult population. Age, chronic medication and cardiac or pulmonary comorbidities have been reported to increase the risk of a severe reaction. Obesity, age and cardiovascular comorbidities have been identified as risk factors for fatal anaphylaxis. However, the risk factors for death after ICU admission have not been elucidated yet.

Conditions

Timeline

Start date
2017-01-01
Primary completion
2019-06-30
Completion
2019-12-31
First posted
2020-03-02
Last updated
2020-03-11

Locations

2 sites across 1 country: France

Source: ClinicalTrials.gov record NCT04290507. Inclusion in this directory is not an endorsement.